Content about Bexarotene

February 21, 2013
Valeant buys rights to Eisai's Targretin

Valeant Pharmaceuticals has bought rights to a drug used to treat skin cancer from Eisai, the companies said Thursday.

May 9, 2012
Seattle Genetics, Millennium start phase-3 trial of Adcetris

Seattle Genetics and Takeda's cancer drug subsidiary have started a late-stage clinical trial for a lymphoma drug, the companies said Wednesday.

October 11, 2011
FDA accepts application for Banner Pharmacaps' generic cancer drug

The Food and Drug Administration has accepted the first regulatory approval application for a generic version of a cancer drug made by Eisai.

© 2013 Drug Store News. All Rights Reserved.